ASCO GI 2022 Combination of docetaxel, cisplatin and 5-FU as a new standard neoadjuvant treatment for oesop... Read more
ASCO GI 2022 Lenvatinib plus transarterial chemoembolisation improves clinical outcomes in patients with ad... Read more
